MedPath

Comparison the effect of intranasal ketamine hydrochloride and intravenous morphine sulfate on pain severity of patients with upper or lower limbs fracture

Phase 2
Conditions
Pain.
Pain in limb
Registration Number
IRCT2016031027007N1
Lead Sponsor
Vice chancellor for research, Ahwaz Judishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
104
Inclusion Criteria

age range of 15 to 64 years; having upper and lower limbs fracture. Exclusion criteria: low of consciousness; hemodynamic instability; addiction to drugs or opioids; mental retardation and psychosis; chronic cardiovascular diseases; being pregnant and breastfeeding; intranasal ketamine hydrochloride and intravenous morphine sulfate contraindication.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain severity. Timepoint: Before intervention and 5, 10, 15, 20, 25 and 30 minutes after intervention. Method of measurement: Visual analog scale.
Secondary Outcome Measures
NameTimeMethod
Vital sign. Timepoint: Before intervention and 5, 10, 15, 20, 25 and 30 minutes after intervention. Method of measurement: Cardiopulmonary monitoring.
© Copyright 2025. All Rights Reserved by MedPath